Author

S. Dalin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

D. A. Lauffenburger· 2 shared A. Luengo· 1 shared A. N. Lau· 1 shared B. Grauman-Boss· 1 shared E. Kreidl· 1 shared M. G. Vander Heiden· 1 shared M. Hemann· 1 shared M. R. Sullivan· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

D. A. Lauffenburger

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Collateral Responses to Classical Cytotoxic Chemotherapies are Heterogeneous and Sensitivities are Sparse

S. Dalin, D. A. Lauffenburger, M. Hemann

The paper examines collateral responses to four classical chemotherapy agents and finds no collateral sensitivities but observes phenotypic heterogeneity unrelated to transcriptomic heterogeneity.

bioRxiv · Apr 15, 2021Cancer Biology

Pancreatic Stellate Cells Secrete Deoxycytidine Conferring Resistance to Gemcitabine in PDAC

S. Dalin, M. R. Sullivan, E. Kreidl, A. N. Lau, B. Grauman-Boss, S. Fenoglio, A. Luengo, M. G. Vander Heiden, D. A. Lauffenburger, M. T. Hemann

This study shows that pancreatic stellate cells secrete deoxycytidine, which reduces the effectiveness of gemcitabine in PDAC by inhibiting its processing in cancer cells.

bioRxiv · Feb 24, 2019Cancer Biology